OFX Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

OFX Group heeft een totaal eigen vermogen van A$173.7M en een totale schuld van A$30.7M, wat de schuld-eigenvermogensverhouding op 17.7% brengt. De totale activa en totale passiva bedragen respectievelijk A$536.0M en A$362.3M. De EBIT OFX Group is A$38.3M waardoor de rentedekking 6.8 is. Het heeft contanten en kortetermijnbeleggingen van A$74.7M.

Belangrijke informatie

17.7%

Verhouding schuld/eigen vermogen

AU$30.69m

Schuld

Rente dekkingsratio	6.8x
Contant	AU$74.69m
Aandelen	AU$173.69m
Totaal verplichtingen	AU$362.31m
Totaal activa	AU$536.00m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Market Cool On OFX Group Limited's (ASX:OFX) Earnings Pushing Shares 31% Lower

Oct 17

OFX Group Limited's (ASX:OFX) Shares Leap 35% Yet They're Still Not Telling The Full Story

May 22

Here's Why We Think OFX Group (ASX:OFX) Might Deserve Your Attention Today

Nov 14

Is Now The Time To Put OFX Group (ASX:OFX) On Your Watchlist?

Jul 07

OFX Group Limited's (ASX:OFX) CEO Might Not Expect Shareholders To Be So Generous This Year

Aug 19

We Wouldn't Be Too Quick To Buy OFX Group Limited (ASX:OFX) Before It Goes Ex-Dividend

Nov 20

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( A$394.3M ) OFX } overtreffen de korte termijn passiva ( A$302.0M ).

Langlopende schulden: De kortetermijnactiva OFX ( A$394.3M ) overtreffen de langetermijnschulden ( A$60.3M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: OFX heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van OFX is de afgelopen 5 jaar gestegen van 0% naar 17.7%.

Schuldendekking: De schuld van OFX wordt goed gedekt door de operationele kasstroom ( 148.1% ).

Rentedekking: De rentebetalingen op de schuld van OFX worden goed gedekt door EBIT ( 6.8 x dekking).

OFX Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

CEO, MD & Executive Director recently bought AU$248k worth of stock

OFX Group Limited to Report First Half, 2026 Results on Nov 11, 2025

First half 2025 earnings released: EPS: AU$0.045 (vs AU$0.065 in 1H 2024)

Price target decreased by 8.6% to AU$2.39

Consensus EPS estimates fall by 19%

OFX Group Limited Provides Earnings Guidance for the Six Months Ended 30 September 2024 and Second Half and Full Year of 2025

Market Cool On OFX Group Limited's (ASX:OFX) Earnings Pushing Shares 31% Lower

Investor sentiment deteriorates as stock falls 36%

CEO, MD & Executive Director recently sold AU$918k worth of stock

Price target increased by 9.3% to AU$2.46

OFX Group Limited's (ASX:OFX) Shares Leap 35% Yet They're Still Not Telling The Full Story

Full year 2024 earnings released: EPS: AU$0.13 (vs AU$0.13 in FY 2023)

Investor sentiment improves as stock rises 21%

OFX Group Limited to Report First Half, 2025 Results on Nov 12, 2024

Non-Executive Independent Director recently bought AU$72k worth of stock

First half 2024 earnings released: EPS: AU$0.065 (vs AU$0.062 in 1H 2023)

Here's Why We Think OFX Group (ASX:OFX) Might Deserve Your Attention Today

OFX Group Limited Announces Change of Company Secretary

OFX Group Limited (ASX:OFX) completed the acquisition of PTRN Pty Ltd.

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improves as stock rises 22%

Investor sentiment deteriorates as stock falls 22%

Price target decreased by 9.0% to AU$2.81

Now 24% undervalued after recent price drop

Investor sentiment deteriorates as stock falls 16%

Now 21% undervalued after recent price drop

CEO, MD & Executive Director recently bought AU$99k worth of stock

Price target increased to AU$3.08

OFX Group Limited Announces Executive Changes

Now 20% undervalued after recent price drop

Consensus EPS estimates increase by 56%

First half 2023 earnings released: EPS: AU$0.06 (vs AU$0.045 in 1H 2022)

OFX Group Limited, Annual General Meeting, Aug 03, 2023

Now 23% undervalued

OFX Group Limited Appoints Patricia Cross as Director

Is Now The Time To Put OFX Group (ASX:OFX) On Your Watchlist?

OFX Group Limited Announces Board Changes

Consensus EPS estimates increase by 13%

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

OFX Group Limited (ASX:OFX) completed the acquisition of FIRMA Foreign Exchange Corporation.

Price target increased to AU$3.00

OFX Group Limited to Report First Half, 2023 Results on Nov 08, 2022

Price target increased to AU$3.00

Consensus EPS estimates increase by 12%

Investor sentiment improved over the past week

OFX Group Limited (ASX:OFX) entered into an agreement to acquire FIRMA Foreign Exchange Corporation for CAD 90 million.

Consensus forecasts updated

First half 2022 earnings released: EPS AU$0.045 (vs AU$0.012 in 1H 2021)

Price target increased to AU$1.85

OFX Group Limited's (ASX:OFX) CEO Might Not Expect Shareholders To Be So Generous This Year

Insider recently bought AU$100k worth of stock

Full year 2021 earnings released: EPS AU$0.053 (vs AU$0.084 in FY 2020)

OFX Group Limited Not Announces Final Dividend for the Year of 2021

Investors In OFX Group Limited (ASX:OFX) Should Consider This, First

Have Insiders Been Buying OFX Group Limited (ASX:OFX) Shares?

New 90-day low: AU$1.15

OFX Group Limited Appoints Catherine Louise Kovacs as A Non-Executive Director

New 90-day high: AU$1.31

OFX Group Limited, Annual General Meeting, Aug 26, 2021

What Percentage Of OFX Group Limited (ASX:OFX) Shares Do Insiders Own?

Is OFX Group Limited (ASX:OFX) A Strong Dividend Stock?

How Is OFX Group's (ASX:OFX) CEO Paid Relative To Peers?

Need To Know: OFX Group Limited (ASX:OFX) Insiders Have Been Buying Shares

We Wouldn't Be Too Quick To Buy OFX Group Limited (ASX:OFX) Before It Goes Ex-Dividend

First half 2021 earnings released: EPS AU$0.012

OFX Group Limited Announces Strategic Alliance with Wisetech Global

New 90-day high: AU$1.33

New 90-day low - AU$1.10

New 90-day low - AU$1.16

New 90-day low - AU$1.24

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven